News Releases Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Email Alerts Year All Years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Keywords Go Advanced Search Keywords Search Headlines Only From To Asset Types Photos Video Audio Documents Events Standard Apr 16, 2012 Insmed Announces First Patient Dosed in Pivotal European Phase 3 Clinical Study of ARIKACE® in Cystic Fibrosis Patients with Pseudomonas Lung Infections Mar 13, 2012 Insmed Announces Fourth Quarter and Full-Year 2011 Financial Results Feb 28, 2012 Insmed to Host Fourth Quarter and 2011 Year-End Earnings Conference Call Feb 10, 2012 Insmed Incorporated Provides Update on Clinical Program for ARIKACE® Jan 20, 2012 Insmed Incorporated Provides Corporate Update Nov 14, 2011 Insmed to Present at Lazard Capital Markets 8th Annual Healthcare Conference Nov 8, 2011 Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2011 Oct 25, 2011 Insmed to Host 2011 Third Quarter Earnings Conference Call Oct 24, 2011 Insmed Incorporated Provides Regulatory Update on ARIKACE® in Non-Tuberculous Mycobacteria Indication Oct 10, 2011 Insmed Incorporated Provides Regulatory Update Show 5102550100 per page«1…36373839404142…69» Stay In The Loop Want to stay up to date on our news, events, and filings? Set up your email alerts. Sign Up View the latest Insmed Investor Presentation Download